for the Medical Technologyand Life Sciences Industry.
Request a Quote
Question: Which Members of Congress might be expected to lead the health policy agenda for the life sciences industry for 2011?
Answer: The 112th Congress convened on January 5, 2011, and as a first order of business, House Republicans have scheduled a vote to repeal the new health care law. Simultaneously, drug and device stakeholders are preparing for upcoming legislative reauthorizations of user fee programs administered by the Food and Drug Administration to speed product reviews. A number of power players will have a role in shaping the health policy environment for the life sciences industry this year; however, some of the key lawmakers to watch include:
For a more detailed analysis on this topic, click here.
Jeff Kimbell is president of Jeffrey J. Kimbell & Associates, a government affairs and health policy firm in Washington, DC.
Legal Notice | Privacy Notice | Trademark Notice | FAQs | Careers
Connect with Us